Humana (NYSE: HUM) reported earnings on Feb. 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Humana missed estimates on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share expanded significantly.

Margins grew across the board.

Revenue details
Humana reported revenue of $9.06 billion. The 10 analysts polled by S&P Capital IQ expected to see revenue of $9.26 billion. Sales were 8.5% higher than the prior-year quarter's $8.35 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.

EPS details
Non-GAAP EPS came in at $1.12. The 18 earnings estimates compiled by S&P Capital IQ predicted $1.20 per share on the same basis. GAAP EPS of $1.20 for Q4 were 90% higher than the prior-year quarter's $0.63 per share.

Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 22.0%, 320 basis points better than the prior-year quarter. Operating margin was 3.8%, 140 basis points better than the prior-year quarter. Net margin was 2.2%, 90 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $10.26 billion. On the bottom line, the average EPS estimate is $1.76.

Next year's average estimate for revenue is $39.06 billion. The average EPS estimate is $8.11.

Investor sentiment

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Humana is outperform, with an average price target of $96.82.

The health-care investing landscape is littered with also-rans and a few major winners. Is Humana prepared for the future? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company Fool co-founder David Gardner believes will deliver amazing returns during the next few years. Click here for instant access to this free report.